Fluid-attenuated inversion recovery (FLAIR) vascular hyperintensity (FVH) is used to assess leptomeningeal collateral circulation, but clinical outcomes of patients with FVH can be very different. The aim of the present study was to assess a FVH score and explore its relationship with clinical outcomes. Patients with acute ischemic stroke due to middle cerebral artery M1 occlusion underwent magnetic resonance imaging and were followed up at 10 days (National Institutes of Health Stroke Scale) and 90 days (modified Rankin Scale) to determine short-term clinical outcomes. Effective collateral circulation indirectly improved recovery of neurological function and short-term clinical outcome by extending the size of the pial penumbra and reducing infarct lesions. FVH score showed no correlation with 90-day functional clinical outcome and was not sufficient as an independent predictor of short-term clinical outcome. 
Introduction
Middle cerebral artery occlusion (MCAO) is one of the most severe ischemic strokes and is always associated with poor functional outcome Gawlitza et al., 2015) . Very early short-term outcome predictors are essential for planning therapeutic strategies during the first few days of stroke onset .
The outcome of acute ischemic stroke (AIS) is influenced by several factors, both non-modifiable (such as gender, age, heredity and race) and modifiable (such as arterial hypertension, hyperlipidemia, diabetes, coronary heart disease, and atrial fibrillation) . Despite a large amount of clinical research into the factors determining AIS outcome, no consensus has been reached . Advances in medical imaging, including in magnetic resonance imaging (MRI), computed tomography angiography (CTA) and computed tomography perfusion (CTP), have enabled more accurate evaluations of AIS severity (Adams et al., 2005; Lee et al., 2009; Sanossian et al., 2009; Azizyan et al., 2011; Guo et al., 2012; Yang et al., 2013; Deng et al., 2016; Dengler et al., 2016; Harteveld et al., 2016; Hernandez-Perez et al., 2016; Husson et al., 2016; Kvistad et al., 2016; Wang et al., 2016b; Yi et al., 2016) . Consequently, the outcomes of patients with AIS can be predicted from evaluations based on factors other than clinical symptoms, and considerable progress has been made in predicting AIS prognosis .
The appearance of fluid-attenuated inversion recovery (FLAIR) vascular hyperintensity (FVH) in stroke patients was first described about 10 years ago (Cosnard et al., 1999; Tsushima and Endo, 2001 ). Slow collateral circulation may explain why FVH is consistent with beneficial collateral arterial flow beyond the arterial occlusion site in AIS patients (Sanossian et al., 2009; Förster et al., 2015; Legrand et al., 2015; Karadeli et al., 2016; Kim et al., 2016; Liu et al., 2016a, b). However, there is little consensus on the determination of prognostic information from FVH (Flacke et al., 2000; Schellinger et al., 2005; Lee et al., 2009) . In previous similar studies, stroke populations were heterogeneous; patients with anterior and posterior circulation occlusions, and with or without thrombolytic treatment, were considered together, potentially confounding results. Furthermore, studies used a variety of prognostic evaluation criteria, including a 10-day National Institutes of Health Stroke Scale (NIHSS) score, the 90-day modified Rankin Scale (mRS) score, and recanalization (Flacke et al., 2000; Schellinger et al., 2005; Lee et al., 2009; Olindo et al., 2012) . To determine the clinical implications of FVH, similar groups of patients should be compared, such as those with similar sites of arterial occlusion, and those receiving similar treatments. In addition, studies should adopt an accepted standard as a prognostic evaluation tool. Here, we use the 90-day mRS score.
The combination of clinical and neuroimaging parameters is of interest because they represent different aspects of stroke-related cerebral impairment. We hypothesized that clinical variables and FVH can provide additive predictive utility for AIS. The aim of the present prospective study was to evaluate the prognostic value of clinical parameters including FVH in AIS patients with M1-middle cerebral artery (MCA) occlusion with respect to 90-day clinical outcome.
Subjects and Methods

Subjects
A single-center cohort study was performed in consecutive AIS patients presenting to the Stroke Unit of Huashan Hospital, China, within 3 hours of onset. The stroke team, including neurophysicians and neuroradiologists, assessed all patients. The patients underwent a computed tomography (CT) + MRIbased stroke protocol, including non-contrast CT, CTP, CTA and MRI, within 72 hours of admission. The study protocol was approved by the institutional review board of Huashan Hospital (approval number: 2013-158) and was conducted in accordance with the Declaration of Helsinki. Close family members or legal guardians gave the informed consent. Study flow chart is shown in Figure 1 .
Inclusion criteria
Patients presenting with all of the following criteria were considered for study inclusion: (1) AIS; (2) isolated M1-MCA occlusion; (3) not receiving thrombolytic therapy; (4) MRI, CTP and CTA obtained within 72 hours of stroke onset; (5) ability to complete 90-day clinical follow-up.
Exclusion criteria
Patients with one or more of the following conditions were excluded from this study: (1) History of brain tumor, cerebral hemorrhage, brain surgery, or other brain disease that might affect prognosis; (2) ischemic stroke in bilateral cerebral hemispheres; (3) posterior circulation infarct; (4) hemorrhagic stroke.
Clinical variables
Clinical data were collected by neuroradiologists and maintained in a prospective stroke database developed by Huashan Hospital. NIHSS was used to evaluate neurologic deficit at admission and 10 days after admission (Schellinger et al., 2005; Lee et al., 2009; Miteff et al., 2009; Tan et al., 2009; Cheng et al., 2012; Olindo et al., 2012) . 90-day mRS was used to evaluate the final functional outcome, with an mRS score > 2 defining poor functional outcome (Miteff et al., 2009; Olindo et al., 2012) . Categorical variables included sex, arterial hypertension, hyperlipidemia, diabetes, coronary heart disease, atrial fibrillation, C-reactive protein increase, history of myocardial infarction, family history of stroke, anticoagulant therapy and anti-platelet therapy. Arterial hypertension was defined as blood pressure > 140/90 mmHg on admission or by the use of an antihypertensive. Hyperlipidemia was defined as serum low-density lipoprotein cholesterol > 140 mg/dL, or serum triglycerides > 150 mg/dL on admission, or use of anti-hyperlipidemia agents. Diabetes was defined as fasting blood glucose > 126 mg/dL or random blood glucose > 200 mg/dL, and hemoglobin A1c > 6.4% on admission (National Glycohemoglobin Standardization Program), or by the use of anti-diabetic agents. Coronary heart disease was defined according to the nomenclature and criteria for diagnosis of ischemic heart disease. Atrial fibrillation was diagnosed by 24-hour ambulatory electrocardiographic monitoring performed on admission. C-reactive protein increase was defined as C-reactive protein > 0.5 mg/dL. Diagnostic criteria for myocardial infarction included documented typical rise and gradual fall (troponin T) or more rapid rise and fall (CK-MB) of biochemical markers of myocardial necrosis with at least one of the following: ischemic symptoms (such as chest pain), development of pathological Q waves on the electrocardiogram, or electrocardiographic changes indicative of ischemia (ST segment elevation or depression), either during admission or in medical reports from other hospitals. All parameters are defined in a study by Li et al. (2015) . A family history of stroke was defined as an immediate family member having had a stroke. Anticoagulants included warfarin and direct oral anticoagulants. Antiplatelet drugs included aspirin, clopidogrel, and cilostazol. Continuous variables included age, admission NIHSS score, 10-day NIHSS score, and 90-day mRS score.
Imaging
All patients underwent non-contrast CT/CTP/CTA and MRI within 72 hours of stroke onset. The stroke protocol was performed on a 256-section CT scanner (Brilliance iCT, Phillips Medical Systems, Cleveland, OH, USA) and 3.0T super-conducting MRI scanner (Verio, Siemens AG, Erlangen, Germany).
Whole-brain no-contrast CT was performed at 120 kV, 150 mA, in contiguous 6 mm axial slices. This was followed by CTP, which included a 50-second scan reconstructed at 0.4-second intervals to produce a series of 312 sequential images for 13 sections, covering a total of 120 mm from the foramen magnum to the lateral ventricles. CTP scanning parameters were as follows: 120 kVp; 150 mAs; slice thickness, 5 mm; field of view (FOV) 220 mm; matrix, 512 × 512, intravenous administration of 50 mL non-ionic contrast (Ultravist Iodine 370 mgI/mL, Bayer Healthcare, Berlin, Germany) at a rate of 5 mL/s via a power injector (Stellate Injection System, Indianola, PA, USA) with a 5-second delay. CTA was performed 10 minutes later from the aortic arch to the vertex with the following parameters: 120 kVp; 150 mAs; slice thickness, 1 mm, pitch, 0.7; FOV, 220 mm, matrix, 512 × 512, helical scanning mode and intravenous administration of 50 mL non-ionic contrast (Ultravist) at 5 mL/s via a power injector (Stellate Injection System) with an 8-second delay. Time to CTP and CTA from stroke onset was 4.55 ± 2.80 hours.
MRI sequences comprised axial T2-weight (repetition time/echo time, 3,480/110 ms; FOV, 240 mm; matrix, 256 × 256; section thickness, 6 mm; gap, 2 mm), T1-FLAIR (repetition time/echo time/inversion time, 1,780/20/860 ms; FOV, 240 mm; matrix, 256 × 256; section thickness, 6 mm; gap, 2 mm), T2-FLAIR (repetition time/echo time/inversion time, 8,600/120/2,370 ms; FOV, 240 mm; matrix, 256 × 256; section thickness, 6 mm; 2-mm gap), diffusion-weighted imaging (DWI) (repetition time/echo time, 4,800/74 ms; FOV, 240 mm; matrix, 256 × 256; section thickness, 6 mm with no gap; b = 0 and 1,000 s/mm 2 ). Axial MRI was performed from the vertex to the foramen magnum, with 16 images per sequence. Time to MRI from stroke onset was 26.14 ± 5.08 hours.
Imaging analysis
CTP data were analyzed with Phillips brain perfusion software (Vision 5.0.2) using an identical deconvolution algorithm to generate parametric maps of mean transit time (MTT) and cerebral blood volume (CBV). An MTT > 145 % of that of the contralateral hemisphere was used to calculate automated MTT lesion volume (Miteff et al., 2009) . Within the MTT lesion, infarct core volume was determined from a CBV map using an automated threshold of < 2.0 mL/100 g (Miteff et al., 2009 ). Thus, penumbral volume was automatically determined from the difference between the MTT lesion and the CBV lesion, and the CTP penumbral/infarct core mismatch ratio was calculated using the formula (MTT lesion − CBV lesion)/CBV lesion.
CTA data were processed using the Phillips Brilliance Workspace portal software (Vision 5.0.2), including 10-mm axial and multi-planar maximum intensity projection reconstructions. MCA occlusion was carried out as described in a study by Lee et al. (2009) . M1-MCA occlusion was defined as a main MCA trunk occlusion before the bifurcation, with or without ipsilateral internal carotid artery occlusion. FVH was defined as a linear or serpentine hyperintensity on the T2-FLAIR image corresponding to a typical arterial course. Absent FVH was defined as no FVH on any T2-FLAIR images. The presence of FVH was categorized as proximal or distal in relation to arterial branching of the MCA: proximal when it was near to or within the Sylvian fissure (i.e., corresponding to the MCA M1 or M2 segments) and distal when it was present at MCA M3 or distal segments. Absent and proximal FVH were grouped together as no distal FVH, because proximal FVH did not offer collateral arterial circulation information. This part of the study was carried out as described in a study from Lee et al. (2009) . The fluid-attenuated inversion recovery (FLAIR) vascular hyperintensity score (longitudinal direction) [FVHS(L)] was based on a rostrocaudal extension of FVH (Olindo et al., 2012) . Thus, all 16 axial T2-FLAIR images were analyzed. Slices with no FVH were scored as 0, and those with one or more FVH were scored as 1. As 16 images were analyzed, the resulting FVH score was 0-16. FLAIR vascular hyperintensity (transverse direction) [FVHS(T)] was scored on a scale of 0-3 (Tan et al., 2007 (Tan et al., , 2009 , with 0 indicating absent FVH in the occluded MCA territory, 1 indicating FVH filling ≤ 50% but > 0% of the occluded MCA territory, 2 indicating FVH filling > 50% but < 100% of the occluded MCA territory, and 3 for 100 % FVH supply of the occluded MCA territory. Two investigators blinded to the other sequence quantified FVHS(L) and FVHS(T). In case of discrepancy between the scores of the two investigators, T2-FLAIR images were reviewed by the investigators until a consensus was established.
The DWI infarct volume was measured on MRI images using Siemens Functool 9.4.05 software. All CTP MTT and CBV lesion volumes and MRI DWI infarct volumes were measured by a third experienced reader who was blinded to the FVH score.
Statistical analysis
Statistical analysis was performed using SPSS 17.0 software (SPSS, Chicago, IL, USA). The Mann-Whitney U and Kruskal-Wallis H tests were used to compare radiological and clinical differences between the groups. Logistic regression analysis of significantly associated variables (P < 0.05) was used to identify factors predictive of a good outcome. Uni- variate and multivariate logistic regression analysis was performed using 90-day mRS score as an outcome variable. The Spearman nonparametric correlation was performed to assess the correlation between variables (NIHSS score, mismatch ratio, infarct volume, FVHS(L) and FVHS(T)) and 90-day mRS score. Inter-observer variability of FVH grading was evaluated with k statistics. A two-tailed value of P < 0.05 was considered significant.
Results
Demographic data
From 134 consecutive AIS patients who met inclusion criteria at admission, 87 were excluded for the following reasons: vertebra-basilar artery territory infarction or lacunar infarction (26), cerebral hemorrhage (23), brain tumor (20), stroke in bilateral cerebral hemispheres (9), brain surgery (7), unreadable FLAIR (5), parasite infections (2), and no follow-up (4). The final cohort comprised 38 AIS patients with M1-MCA occlusion (including 9 with ipsilateral internal carotid artery occlusion): mean age was 62.52 ± 13.61 years and 13 (34%) were women. The 90-day mRS scores are shown in Table 1 . Poor clinical outcome was seen in 24 patients (63%).
Comparison of clinical variables between MCAO patients with poor and good clinical outcomes
There was no significant difference between the patients with poor and good clinical outcomes in terms of gender, age, arterial hypertension, hyperlipidemia, diabetes, coronary heart disease, atrial fibrillation, C-reactive protein increase, history of myocardial infarction, family history of stroke, anticoagulant therapy or anti-platelet therapy ( Table 2) .
Relationship between NIHSS score and 90-day mRS score Mean admission NIHSS score was 13.29 ± 3.11. Mean 10-day NIHSS score was 12.12 ± 5.25. Patients with poor clinical outcomes had higher admission NIHSS score (P < 0.001), and higher 10-day NIHSS score (P < 0.001) ( Table 2 ). There was a positive correlation between 90-day mRS score and both NIHSS scores (admission and 10-day) (P < 0.001 for all parameters) ( Table 1 . Sixteen had no distal FVH, meaning their corresponding FVHS(L) and FVHS(T) were 0. Patients with poor clinical outcomes had larger infarct volumes (P < 0.001) and smaller mismatch ratios (P = 0.011; Table 2 ). No differences in distal FVH, FVHS(L) or FVHS(T) were found between the poor and good clinical outcome groups (P > 0.05; Table  2 ), and no difference in 90-day mRS score was detectable among the FVHS(L) = 3-4, FVHS(L) = 5-6 or FVHS(L) = 7-8 groups. Similarly, no difference in 90-day mRS score was found between the FVHS(T) = 1 and FVHS(T) = 2-3 groups. The 90-day mRS score was positively correlated with infarct volume, and negatively with mismatch ratio (P < 0.001 for all parameters). The 90-day mRS score was not correlated with FVHS(L) and FVHS(T) (P = 0.421 and 0.160, respectively; Table 3 ). Logistic regression analysis demonstrated that neither infarct volume nor FVHS(T) were found to be independent variables associated with functional clinical outcome in the present model ( Tables 4, 5 , and Figure 2 ).
Discussion
This study was conducted to find useful predictors for shortterm functional outcome in AIS patients with M1-MCA occlusion. Our findings demonstrated that 10-day NIHSS score was positively correlated with 90-day mRS score and independently predicted 90-day functional outcome. In contrast, FVHS(L) and FVHS(T) had no correlation with the 90-day mRS score, and did not independently predict 90-day functional outcome in patients with AIS with M1-MCA occlusion.
Age is a powerful predictor of mortality and functional outcome after AIS (Weimar et al., 2004; König et al., 2008; Sato et al., 2008; Maruyama et al., 2017) . However, we did not find a significant difference in age or other clinical variables between our two groups (poor and good clinical outcome). The small sample size and strict inclusion criteria in our study may explain this apparent discrepancy.
In the mid-1980s, the NIHSS was developed for the evaluation of AIS patients (Brott et al., 1989) . Today, it is the standard instrument used for the assessment of patients with suspected ischemic stroke (Adams et al., 1999; Dancer et al., 2009; Lyden et al., 2009; Tan et al., 2009; Jauch et al., 2013) . Many studies found that NIHSS score was the most powerful predictor of functional outcome and mortality after AIS (Woo et al., 1999; Fink et al., 2002; Wechsler et al., 2003; Weimar et al., 2004; Kimura et al., 2008; König et al., 2008; Sato et al., 2008; Nogueira et al., 2009; Olindo et al., 2012; Maruyama et al., 2017; Villalobos et al., 2017) . Consistent with these reports, we found that NIHSS score was associated with 90-day functional outcome after AIS.
However, the NIHSS has been criticized for being biased towards language, meaning that cross-language or cross-cultural misinterpretations may occur (Woo et al., 1999; Fink et al., 2002) . This has the potential to misguide treatment decisions (Villalobos et al., 2017) . Therefore, a convenient and reproducible scoring system, to be used with NIHSS score, is necessary.
Increasingly, MRI is being used to evaluate and manage AIS within the first hours of occurrence, and it might be more effective than CT (Chalela et al., 2007) . Evaluation of collateral supply remains challenging due to the small size and complex routes of vessels (Liebeskind, 2003) . Important information on early collateral circulation can be provided by FVH (Sanossian et al., 2009; Chan et al., 2016; Gerber et al., 2016; Liu et al., 2016a; van Seeters et al., 2016) . In this study, we used a very simple points system to longitudinally quantify FVH by counting images on 16 standardized 6-mm-thick T2-FLAIR sequences to allow quantification from the proximal temporal territory to the distal parietal MCA territory. Furthermore, a modified collateral score was previously proposed in which a high-resolution multi-detector CTA would be used to grade the degree of leptomeningeal collateral supply in the MCA territory from 0 (no collateral supply) to 3 (complete collateral supply) (Tan et al., 2007 (Tan et al., , 2009 ). We call this FVHS(T), and physicians can obtain these scores on routine MRIs, considerably more easily than other scores requiring MRI perfusion analysis. In addition, the FVH inter-observer agreement was excellent and images can be scored easily. Although somewhat crude, FLAIR-derived FVHS(L) and FVHS(T) provide simple and reproducible assessment of collateral circulation.
Good collateral blood flow in AIS is known to influence prognosis (Bozzao et al., 1989; Roberts et al., 2002; Kucinski et al., 2003; Christoforidis et al., 2005; Lee et al., 2009; Maas et al., 2009; Lima et al., 2010) . In our previous study, we showed that patients with lower FVH score were more likely to have a smaller CTP penumbral/infarct core mismatch ratio and larger infarct volume (Li et al., 2017) . As a result, patients with a lower FVH score could represent poor collateral circulation, and our conclusion would be in accordance with studies that established the importance of collateral supply to predict infract volume (Bozzao et al., 1989; Christoforidis et al., 2005; Lee et al., 2009 ). However, although FVHS(L) and FVHS(T) were associated with 90-day mRS scores, they were not found to be independent variables in our multivariate regression analysis. The clinical significance of FVH may reflect a larger CTP penumbral/infarct core mismatch ratio and a smaller infarct volume; in addition, the small sample size of our study might explain this discrepant finding.
Collateral circulation prolongs tissue viability and maximizes the volume of salvageable tissue, and therefore has considerable clinical implications for treatment decisions after AIS (Lee et al., 2000; Qureshi, 2002; Higashida et al., 2003; Liebeskind, 2005; Ovbiagele et al., 2007; Hendrikse et al., 2008; Tan et al., 2009; Lima et al., 2010; Guo et al., 2012; Wang et al., 2013 Wang et al., , 2016a Pereira et al., 2015; Akiyama et al., 2016; Cai et al., 2016; Da Ros et al., 2016; Mao et al., 2016; Wen et al., 2016; Tso et al., 2017) . Our findings and previous reported cases (Ovbiagele et al., 2007; McVerry et al., 2012; Chan et al., 2016) indicate that collateral blood flow is a potential therapeutic target. But for targeting collateral vessels in stroke therapy, there must be consistency in the examination of their extent at baseline, to permit further expansion in this field.
The study has some limitations. First, as a mono-center small-sample analysis of a homogeneous population, patient selection bias is possible. Second, FVH is difficult to observe in some new MRI developments, such as 3D FLAIR and synthetic techniques.
In summary, there is ongoing extensive research worldwide into clinical and radiologic predictors to help determine favorable clinical outcomes in AIS. No single parameter can predict outcome accurately, and it is clear that a predictive model must incorporate a number of easily derived and reliable factors. In this study, our findings showed that 10-day NIHSS scores correlated positively with 90-day mRS scores and independently predicted 90-day functional outcomes of AIS patients with MCAO. In addition, we demonstrated that neither FVHS(L) nor FVHS(T) were independent variables associated with 90-day mRS scores. Whether these results will aid therapeutic strategies remains to be determined. China (approval number: 2013-158 
